New agents in non-small cell lung cancer

This publication has 37 references indexed in Scilit:

• Phase II study of 9-hydroxy-2N-methylellipticinium acetate
  European Journal of Cancer and Clinical Oncology, 1984
• High-dose methotrexate with leucovorin rescue in patients with unresectable non-small cell carcinoma of the lung
  Cancer, 1983
• A randomized phase II study of m-AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non-small cell broncliogenic carcinoma
  American Journal of Clinical Oncology, 1983
• Clinical trials with the hexitol derivatives in the U.S.
  Cancer, 1981
• Clinical study of vincristine in adenocarcinoma of the lung: A study of the Early-Clinical-Trial Group of the E.O.R.T.C.
  Published by Elsevier ,1980
• Prognostic effect of weight loss prior tochemotherapy in cancer patients
  The American Journal of Medicine, 1980
• The Development of Mesna for the Inhibition of Urotoxic Side Effects of Cyclophosphamide, Ifosfamide, and Other Oxazaphosphorine Cytostatics
  Published by Springer Nature ,1980
• Potential CNS Antitumor Agents VI: Aziridinylbenzoquinones III
  Journal of Pharmaceutical Sciences, 1979
• Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone
  Journal of Medicinal Chemistry, 1975
• Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer
  Cancer, 1972